Annual Interest Expense
$2.42 M
-$4.66 M-65.84%
31 December 2023
Summary:
Supernus Pharmaceuticals annual interest expense is currently $2.42 million, with the most recent change of -$4.66 million (-65.84%) on 31 December 2023. During the last 3 years, it has fallen by -$21.34 million (-89.83%). SUPN annual interest expense is now -89.83% below its all-time high of $23.75 million, reached on 31 December 2020.SUPN Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$0.00
$0.000.00%
30 September 2024
Summary:
Supernus Pharmaceuticals quarterly interest expense is currently $0.00, unchanged on 30 September 2024. Over the past year, it has stayed the same.SUPN quarterly interest expense is now -100.00% below its all-time high of $6.10 million, reached on 31 March 2021.SUPN Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$0.00
$0.000.00%
30 September 2024
Summary:
Supernus Pharmaceuticals TTM interest expense is currently $0.00, unchanged on 30 September 2024. Over the past year, it has dropped by -$4.01 million (-100.00%). SUPN TTM interest expense is now -100.00% below its all-time high of $24.10 million, reached on 31 March 2021.SUPN TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SUPN Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -65.8% | 0.0% | -100.0% |
| 3 y3 years | -89.8% | -100.0% | -100.0% |
| 5 y5 years | -86.7% | -100.0% | -100.0% |
SUPN Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -89.8% | at low | -100.0% | -100.0% | ||
| 5 y | 5 years | -89.8% | at low | -100.0% | -100.0% | ||
| alltime | all time | -89.8% | -100.0% | +100.0% | -100.0% | +100.0% |
Supernus Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2024 | - | $0.00(0.0%) | $910.00 K(-62.3%) |
| Dec 2023 | $2.42 M(-65.8%) | $0.00(0.0%) | $2.42 M(-39.8%) |
| Sept 2023 | - | $0.00(-100.0%) | $4.01 M(-30.1%) |
| June 2023 | - | $910.00 K(-39.5%) | $5.73 M(-13.6%) |
| Mar 2023 | - | $1.50 M(-5.6%) | $6.63 M(-6.2%) |
| Dec 2022 | $7.07 M(-69.8%) | $1.59 M(-7.5%) | $7.07 M(-38.0%) |
| Sept 2022 | - | $1.72 M(-4.8%) | $11.41 M(-26.9%) |
| June 2022 | - | $1.81 M(-6.8%) | $15.61 M(-19.0%) |
| Mar 2022 | - | $1.94 M(-67.3%) | $19.27 M(-17.7%) |
| Dec 2021 | $23.42 M(-1.4%) | $5.93 M(+0.2%) | $23.42 M(-0.7%) |
| Sept 2021 | - | $5.92 M(+8.4%) | $23.59 M(-0.7%) |
| June 2021 | - | $5.47 M(-10.3%) | $23.75 M(-1.4%) |
| Mar 2021 | - | $6.10 M(+0.0%) | $24.10 M(+1.4%) |
| Dec 2020 | $23.75 M(+4.6%) | $6.10 M(+0.1%) | $23.75 M(+1.4%) |
| Sept 2020 | - | $6.09 M(+4.7%) | $23.43 M(+1.9%) |
| June 2020 | - | $5.82 M(+1.0%) | $23.01 M(+1.9%) |
| Mar 2020 | - | $5.75 M(-0.4%) | $22.58 M(-0.5%) |
| Dec 2019 | $22.71 M(+25.4%) | $5.78 M(+2.0%) | $22.70 M(+0.8%) |
| Sept 2019 | - | $5.66 M(+5.1%) | $22.52 M(+0.4%) |
| June 2019 | - | $5.39 M(-8.2%) | $22.42 M(-0.6%) |
| Mar 2019 | - | $5.87 M(+4.8%) | $22.56 M(+24.6%) |
| Dec 2018 | $18.11 M(+1055.0%) | $5.60 M(+0.6%) | $18.11 M(+43.1%) |
| Sept 2018 | - | $5.57 M(+0.7%) | $12.66 M(+74.7%) |
| June 2018 | - | $5.53 M(+289.8%) | $7.25 M(+274.1%) |
| Mar 2018 | - | $1.42 M(+871.2%) | $1.94 M(+23.5%) |
| Dec 2017 | $1.57 M | $146.00 K(-5.8%) | $1.57 M(-33.9%) |
| Sept 2017 | - | $155.00 K(-28.9%) | $2.37 M(-30.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | $218.00 K(-79.2%) | $3.42 M(-26.9%) |
| Mar 2017 | - | $1.05 M(+10.4%) | $4.68 M(-8.0%) |
| Dec 2016 | $5.09 M(+6.7%) | $950.00 K(-21.2%) | $5.09 M(-5.3%) |
| Sept 2016 | - | $1.21 M(-18.3%) | $5.38 M(-1.5%) |
| June 2016 | - | $1.48 M(+1.3%) | $5.46 M(+7.3%) |
| Mar 2016 | - | $1.46 M(+18.0%) | $5.09 M(+6.7%) |
| Dec 2015 | $4.77 M(-15.1%) | $1.24 M(-4.2%) | $4.77 M(-5.6%) |
| Sept 2015 | - | $1.29 M(+16.8%) | $5.05 M(-6.0%) |
| June 2015 | - | $1.10 M(-3.2%) | $5.38 M(-3.1%) |
| Mar 2015 | - | $1.14 M(-25.0%) | $5.55 M(-1.2%) |
| Dec 2014 | $5.62 M(-28.4%) | $1.52 M(-5.8%) | $5.62 M(-9.4%) |
| Sept 2014 | - | $1.61 M(+26.4%) | $6.21 M(-16.8%) |
| June 2014 | - | $1.28 M(+5.9%) | $7.46 M(-10.4%) |
| Mar 2014 | - | $1.21 M(-42.7%) | $8.33 M(+6.1%) |
| Dec 2013 | $7.85 M(+119.6%) | $2.11 M(-26.6%) | $7.85 M(+19.9%) |
| Sept 2013 | - | $2.87 M(+33.9%) | $6.54 M(+43.7%) |
| June 2013 | - | $2.14 M(+194.9%) | $4.55 M(+36.4%) |
| Mar 2013 | - | $727.00 K(-9.6%) | $3.34 M(-6.6%) |
| Dec 2012 | $3.58 M(+91.6%) | $804.00 K(-8.6%) | $3.58 M(+9.0%) |
| Sept 2012 | - | $880.00 K(-5.3%) | $3.28 M(+13.1%) |
| June 2012 | - | $929.00 K(-3.4%) | $2.90 M(+17.4%) |
| Mar 2012 | - | $962.00 K(+89.0%) | $2.47 M(+32.2%) |
| Dec 2011 | $1.87 M(>+9900.0%) | $509.00 K(+2.0%) | $1.87 M(-122.0%) |
| Sept 2011 | - | $499.00 K(0.0%) | -$8.47 M(-5.6%) |
| June 2011 | - | $499.00 K(+38.6%) | -$8.97 M(-5.3%) |
| Mar 2011 | - | $360.00 K(-103.7%) | -$9.47 M(-3.7%) |
| Dec 2010 | $0.00(0.0%) | -$9.83 M(+6.7%) | -$9.83 M(+6.7%) |
| Dec 2009 | $0.00(-100.0%) | -$9.21 M | -$9.21 M |
| Dec 2008 | $8.68 M(>+9900.0%) | - | - |
| Dec 2007 | $0.00 | - | - |
FAQ
- What is Supernus Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual interest expense year-on-year change?
- What is Supernus Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly interest expense year-on-year change?
- What is Supernus Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals TTM interest expense year-on-year change?
What is Supernus Pharmaceuticals annual interest expense?
The current annual interest expense of SUPN is $2.42 M
What is the all time high annual interest expense for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual interest expense is $23.75 M
What is Supernus Pharmaceuticals annual interest expense year-on-year change?
Over the past year, SUPN annual interest expense has changed by -$4.66 M (-65.84%)
What is Supernus Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of SUPN is $0.00
What is the all time high quarterly interest expense for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly interest expense is $6.10 M
What is Supernus Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, SUPN quarterly interest expense has changed by $0.00 (0.00%)
What is Supernus Pharmaceuticals TTM interest expense?
The current TTM interest expense of SUPN is $0.00
What is the all time high TTM interest expense for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high TTM interest expense is $24.10 M
What is Supernus Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, SUPN TTM interest expense has changed by -$4.01 M (-100.00%)